Basal cell carcinoma and squamous cell carcinoma growth rates and determinants of size in community patients - 14/02/14
, Bruce Armstrong, D Phil a, Vibeke Hansen, BA (Hons) b, Alan Watson, MD c, Gurpreet Singh-Khaira, MD d, Christophe Lecathelinais, DESS de Mathématiques Appliquées e, Chris Goumas, MPH a, Afaf Girgis, PhD fAbstract |
Background |
Cutaneous basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) have poorer outcomes if treated when large.
Objective |
We sought to estimate the growth rate of BCCs and SCCs and examine the relationship of personal, pathway, and cancer factors with cancer size (diameter).
Methods |
We surveyed patients, pathology, and treatment for invasive BCCs and SCCs in 1 Australian region in 2000 through 2001.
Results |
BCC size increased with increasing time since first noticed. Relative to mean size at 0 to 2 months, the mean size ratio was 1.10 at 2 to 8 months and increased steadily to 1.81 at 5 to 10 years (P < .001). Few BCCs were untreated beyond 10 years. There was no consistent evidence that SCC size increased with increasing time. Larger BCCs were independently associated with older age, male sex, no skin checks by a physician, aggressive tumor type, ulceration and lesion-associated scar tissue, and larger SCCs with male sex, skin checks by a physician every 1 to 3 months, and location on limbs.
Limitations |
Patient recall of dates and lack of thickness for SCCs are limitations.
Conclusion |
Earlier diagnosis of BCCs, perhaps through skin checks by a physician, may reduce their size and improve outcome. SCC size did not evidently increase with time.
Le texte complet de cet article est disponible en PDF.Key words : basal cell carcinoma, cancer size, growth rate, skin cancer, squamous cell carcinoma
Abbreviations used : BCC, GM, MR, SCC
Plan
| Supported by the National Health and Medical Research Council of Australia grant number 100920. |
|
| Conflicts of interest: None declared. |
|
| Reprints not available from the authors. |
Vol 70 - N° 3
P. 456-464 - mars 2014 Retour au numéro
Article précédent
- Clinical utility of a circulating tumor cell assay in Merkel cell carcinoma
- Astrid Blom, Shailender Bhatia, Stephanie Pietromonaco, Karen Koehler, Jayasri G. Iyer, Kotaro Nagase, Kelly Paulson, Daniel E. Sabath, Paul Nghiem
- Incidence of primary skin cancer after organ transplantation: An 18-year single-center experience in Korea
- Gyeong-Hun Park, Sung Eun Chang, Chong Hyun Won, Mi Woo Lee, Jee Ho Choi, Kee Chan Moon, Duck Jong Han, Su Kil Park, Jae-Joong Kim, Jae Won Lee, Sung-Gyu Lee
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?